Hypomethylation of DNA promoter upregulates ADAMTS7 and contributes to HTR-8/SVneo and JEG-3 cells abnormalities in pre-eclampsia

Mol, 2016, Pre-eclampsia, Lancet, 387, 999, 10.1016/S0140-6736(15)00070-7 Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726 Rana, 2019, Preeclampsia, Circ Res., 124, 1094, 10.1161/CIRCRESAHA.118.313276 Chaiworapongsa, 2014, Pre-eclampsia part 1: current understanding of its pathophysiology, Nat. Rev. Nephrol., 10, 466, 10.1038/nrneph.2014.102 Roberts, 2005, Preeclampsia: recent insights, Hypertension, 46, 1243, 10.1161/01.HYP.0000188408.49896.c5 Burton, 2019, Pre-eclampsia: pathophysiology and clinical implications, BMJ, 366, l2381, 10.1136/bmj.l2381 Kamrani, 2019, The role of epigenetic changes in preeclampsia, Biofactors, 10.1002/biof.1542 Jones, 2012, Functions of DNA methylation: islands, start sites, gene bodies and beyond, Nat. Rev. Genet., 13, 484, 10.1038/nrg3230 Li, 2018, Ten-eleven translocation 2 demethylates the MMP9 promoter, and its down-regulation in preeclampsia impairs trophoblast migration and invasion, J. Biol. Chem., 293, 10059, 10.1074/jbc.RA117.001265 Januar, 2015, Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference, Am. J. Obstet. Gynecol., 213, S182, 10.1016/j.ajog.2015.07.011 Nelissen, 2011, Epigenetics and the placenta, Hum. Reprod. Update, 17, 397, 10.1093/humupd/dmq052 Rahat, 2016, Association of aberrant methylation at promoter regions of tumor suppressor genes with placental pathologies, Epigenomics, 8, 767, 10.2217/epi.16.7 Harati-Sadegh, 2019 Stryker, 2019, Evaluation of angiogenesis assays, Biomedicines, 7, 10.3390/biomedicines7020037 Goodwin, 2007, In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents, Microvasc. Res., 74, 172, 10.1016/j.mvr.2007.05.006 Wells, 2015, MMP generated matrikines, Matrix Biol., 44–46, 122, 10.1016/j.matbio.2015.01.016 Yamamoto, 2015, Extracellular regulation of metalloproteinases, Matrix Biol., 44–46, 255, 10.1016/j.matbio.2015.02.007 Zhong, 2019, A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease, Biochem. Pharmacol., 164, 188, 10.1016/j.bcp.2019.03.033 Namli Kalem, 2018, ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia, Hypertens. Pregnancy, 37, 9, 10.1080/10641955.2017.1397690 Xiao, 2017, Expression of ADAMTS13 in normal and abnormal placentae and its potential role in angiogenesis and placenta development, Arterioscler. Thromb. Vasc. Biol., 37, 1748, 10.1161/ATVBAHA.117.309735 Luan, 2008, Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin, Osteoarthritis Cartilage, 16, 1413, 10.1016/j.joca.2008.03.017 Bauer, 2015, Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice, Circulation, 131, 1202, 10.1161/CIRCULATIONAHA.114.012669 Kessler, 2015, ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1, Circulation, 131, 1191, 10.1161/CIRCULATIONAHA.114.014072 Zhang, 2015, The function and roles of ADAMTS-7 in inflammatory diseases, Mediat. Inflamm., 801546 Liu, 2006, ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein, Faseb. J., 20, 988, 10.1096/fj.05-3877fje Wagstaff, 2011, The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis, Front Biosci (Landmark Ed)., 16, 1861, 10.2741/3827 Xu, 2017, Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-kappaB signaling, Cancer Med, 6, 1399, 10.1002/cam4.1076 Kumar, 2012, ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity, Am. J. Pathol., 181, 1056, 10.1016/j.ajpath.2012.05.022 Yeung, 2016, DNA methylation profiles in preeclampsia and healthy control placentas, Am. J. Physiol. Heart Circ. Physiol., 310, H1295, 10.1152/ajpheart.00958.2015 Liu, 2017, Increased tissue factor expression and promoter hypomethylation in preeclampsia placentas in a Chinese population, Pregnancy Hypertens, 10, 90, 10.1016/j.preghy.2017.06.008 Kordowski, 2018, Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers, BMC Canc., 18, 796, 10.1186/s12885-018-4701-2 Rana, 2019, Preeclampsia: pathophysiology, challenges, and perspectives, Circ. Res., 124, 1094, 10.1161/CIRCRESAHA.118.313276 Martin, 2015, Recombinant disintegrin domain of human ADAM9 inhibits migration and invasion of DU145 prostate tumor cells, Cell Adhes. Migrat., 9, 293, 10.4161/19336918.2014.994917